Interleukin-2 Receptor β Chain in Leukemias and Lymphomas

References

• Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: Parameters of production and a quantitative microassay for activity. Journal of Immunology 1978; 120: 2027–32
   PubMed Web of Science ®Google Scholar
• Smith K. A. T-cell growth factor. Immunology Reviews 1980; 51: 337–57
   PubMed Web of Science ®Google Scholar
• Larsson E.-L., Iscove N. N., Coutinho A. Two distinct factors are required for induction of T-cell growth. Nature 1980; 283: 664–6
   PubMed Web of Science ®Google Scholar
• Gillis S. Interleukin-2: Biology and biochemistry. Journal of Clinical Immunology 1983; 3: 1–13
   PubMed Web of Science ®Google Scholar
• Smith K. A. Interleukin-2. Annual Review of Immunology 1984; 2: 319–33
   PubMed Web of Science ®Google Scholar
• Meuer S. C., Hussey R. E., Cantrell D. A., Hodgdon J. C., Schlossman S. F., Smith K. A., Reinherz E. L. Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proceedings of the National Academy of Science of the United States of America 1984; 81: 1509–13
   PubMed Web of Science ®Google Scholar
• Mingari M. C., Gerosa F., Carra G., Accolla R. S., Moretta A., Zubler R. H., Waldmann T. A., Moretta L. Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 1984; 312: 641–3
   PubMed Web of Science ®Google Scholar
• Henney C. S., Kuribayashi K., Kern D. E., Gillis S. Interleukin-2 augments natural killer cell activity. Nature 1981; 291: 335–8
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Biology of natural killer cells. Advances in Immunology 1989; 47: 187–376
   PubMed Web of Science ®Google Scholar
• Grimm E. A., Mazumder A., Zhang H. Z., Rosenberg S. A. The lymphokine activated killer cell phenomenon: lysis of NK-resistant fresh solid tumor cells by IL-2 activated autologous human peripheral blood lymphocytes. Journal of Experimental Medicine 1982; 155: 1823–41
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A., Lotze M. T., Muul L. M., Leitman S., Chang A. E., Ettinghausen S. E., Matory Y. L., Skibber J. M., Shiloni E., Seipp C. A., Simpson C., Reichert C. M. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. New England Journal of Medicine 1985; 313: 1485–92
   PubMed Web of Science ®Google Scholar
• Waldmann T. A. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science 1986; 232: 727–32
   PubMed Web of Science ®Google Scholar
• Smith K. A. Interleukin-2: inception, impact, and implications. Science 1988; 240: 1169–76
   PubMed Web of Science ®Google Scholar
• Waldmann K. A. The multi-subunit interleukin-2 receptor. Annual Review of Biochemistry 1989; 58: 875–911
   PubMed Web of Science ®Google Scholar
• Waldmann T. A. IL-2 receptor expression in haematologic malignancies: a target for immunotherapy. Cancer Surveys 1989; 8: 891–903
   PubMedGoogle Scholar
• Allouche M., Sahraoui Y., Augery-Bourget Y., Perrakis M., Jasmin C., Georgoulias V. Interleukin 2 receptors. Leukemia Research 1990; 14: 699–703
   PubMed Web of Science ®Google Scholar
• Waldmann T. A. The interleukin-2 receptor. Journal of Biological Chemistry 1990; 266: 2681–4
   Web of Science ®Google Scholar
• Robb R. J., Munck A., Smith K. A. T cell growth factor receptors: Quantitation, specificity, and biological relevance. Journal of Experimental Medicine 1981; 154: 1455–74
   PubMed Web of Science ®Google Scholar
• Uchiyama T., Broder S., Waldmann T. A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. Journal of Immunology 1981; 126: 1393–7
   PubMed Web of Science ®Google Scholar
• Leonard W. J., Depper J. M., Uchiyama T., Smith K. A., Waldmann T. A., Greene W. C. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature 1982; 300: 267–9
   PubMed Web of Science ®Google Scholar
• Depper J. M., Leonard W. J., Robb R. J., Waldmann T. A., Greene W. C. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. Journal of Immunology 1983; 131: 690–6
   PubMed Web of Science ®Google Scholar
• Miyawaki T., Yachie A., Uwadana N., Ohzeki S., Nagaoki T., Taniguchi N. Functional significance of Tac antigen expressed on activated human T lymphocytes: Tac antigen interacts with T cell growth factor in cellular proliferation. Journal of Immunology 1982; 129: 2474–8
   PubMed Web of Science ®Google Scholar
• Leonard W. J., Depper J. M., Robb R. J., Waldmann T. A., Greene W. C. Characterization of the human receptor for T-cell growth factor. Proceedings of the National Academy of Science of the United States of America 1983; 80: 6957–61
   PubMed Web of Science ®Google Scholar
• Leonard W. J., Depper J. M., Crabtree G. R., Rudikoff S., Pumphrey J., Robb R. J., Krönke M., Svetlik P. B., Peffer N. J., Waldmann T. A., Greene W. C. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 1984; 311: 626–31
   PubMed Web of Science ®Google Scholar
• Nikaido T., Shimizu A., Ishida N., Sabe H., Teshigawara K., Maeda M., Uchiyama T., Yodoi J., Honjo T. Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 1984; 311: 631–5
   PubMed Web of Science ®Google Scholar
• Cosman D., Cerretti D. P., Larsen A., Park L., March C., Dower S., Gillis S., Urdal D. Cloning sequence and expression of human interleukin-2 receptor. Nature 1984; 312: 768–71
   PubMed Web of Science ®Google Scholar
• Greene W. C., Robb R. J. Receptors for T-cell growth factor: structure, function, and expression on normal and neoplastic cells. Contemporary Topics in Molecular Immunology 1984; 10: 1–34
   Google Scholar
• Robb R. J., Greene W. C., Rusk C. M. Low and high affinity cellular receptors for interleukin 2: Implications for the level of Tac antigen. Journal of Experimental Medicine 1984; 160: 1126–46
   PubMed Web of Science ®Google Scholar
• Hatakeyama M., Minamoto S., Uchiyama T., Hardy R. R., Yamada G., Taniguchi T. Reconstitution of functional receptor for human interleukin-2 in mouse cells. Nature 1985; 318: 467–70
   PubMed Web of Science ®Google Scholar
• Kondo S., Shimizu A., Maeda M., Tagaya Y., Yodoi J., Honjo T. Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfection. Nature 1986; 320: 75–7
   PubMed Web of Science ®Google Scholar
• Greene W. C., Robb R. J., Svetlik P. B., Rusk C. M., Depper J. M., Leonard W. J. Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells. Journal of Experimental Medicine 1985; 162: 363–8
   PubMed Web of Science ®Google Scholar
• Tsudo M., Kozak R. W., Goldman C. K., Waldmann T. A. Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex. Proceedings of the National Academy of Science of the United States of America 1987; 84: 4215–8
   PubMed Web of Science ®Google Scholar
• Wang H.-M., Smith K. A. The interleukin 2 receptor. Functional consequences of its bimolecular structure. Journal of Experimental Medicine 1987; 166: 1055–67
   PubMed Web of Science ®Google Scholar
• Dukovich M., Wano Y., Le thi Bich Thuy, Katz P., Cullen B. R., Kehrl J. H., Greene W. C. A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors. Nature 1987; 327: 518–22
   PubMed Web of Science ®Google Scholar
• Tsudo M., Kozak R. W., Goldman C. K., Waldmann T. A. Demonstration of a non-Tac peptide that binds interleukin 2: A potential participant in a multichain interleukin 2 receptor complex. Proceedings of the National Academy of Science of the United States of America 1986; 83: 9694–8
   PubMed Web of Science ®Google Scholar
• Teshigawara K., Wang H.-M., Kato K., Smith K. A. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. Journal of Experimental Medicine 1987; 165: 227–38
   Web of Science ®Google Scholar
• Sharon M., Klausner R. D., Cullen B. R., Chizzonite R., Leonard W. J. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science 1986; 234: 859–63
   PubMed Web of Science ®Google Scholar
• Robb R. J., Rusk C. M., Yodoi J., Greene W. C. Interleukin 2 binding molecule distinct from the Tac protein: Analysis of its role in formation of high-affinity receptors. Proceedings of the National Academy of Science of the United States of America 1987; 84: 2002–6
   PubMed Web of Science ®Google Scholar
• Lê Thi Bich-Thuy, Dukovich M., Peffer N. J., Fauci A. S., Kehrl J. H., Greene W. C. Direct activation of human resting T cells by IL 2: The role of an IL 2 receptor distinct from the Tac protein. Journal of Immunology 1987; 139: 1550–6
   PubMed Web of Science ®Google Scholar
• Robb R. J., Greene W. C. Internalization of interleukin 2 is mediated by the β chain of the high-affinity interleukin 2 receptor. Journal of Experimental Medicine 1987; 165: 1201–6
   PubMed Web of Science ®Google Scholar
• Tanaka T., Saiki O., Doi S., Negoro S., Kishimoto S. Interleukin 2 functions through novel interleukin 2 binding molecules in T cells. Journal of Immunology 1988; 140: 470–3
   PubMed Web of Science ®Google Scholar
• Tanaka T., Saiki O., Doi S., Fuji M., Sugamura K., Hara H., Negoro S., Kishimoto S. Novel receptor-mediated internalization of interleukin 2 in B cells. Journal of Immunology 1988; 140: 866–70
   PubMed Web of Science ®Google Scholar
• Tsudo M., Goldman C. K., Bongiovanni K. F., Chan W. C., Winton E. F., Yagita M., Grimm E. A., Waldmann T. A. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proceedings of the National Academy of Science of the United States of America 1987; 84: 5394–8
   PubMed Web of Science ®Google Scholar
• Siegel J. P., Sharon M., Smith P. L., Leonard W. J. The IL-2 receptor β chain (p70): Role in mediating signals for LAK, NK, and proliferative activities. Science 1987; 238: 75–8
   PubMed Web of Science ®Google Scholar
• Kehrl J. H., Dukovich M., Whalen G., Katz P., Fauci A. S., Greene W. C. Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. Journal of Clinical Investigation 1988; 81: 200–5
   PubMed Web of Science ®Google Scholar
• Nakamura Y., Inamoto T., Sugie K., Masutani H., Shindo T., Tagaya Y., Yamauchi A., Ozawa K., Yodoi J. Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes. Proceedings of the National Academy of Science of the United States of America 1989; 86: 1318–22
   PubMed Web of Science ®Google Scholar
• Tsudo M., Kitamura F., Miyasaka M. Characterization of the interleukin 2 receptor β chain using three distinct monoclonal antibodies. Proceedings of the National Academy of Science of the United States of America 1989; 86: 1982–6
   PubMed Web of Science ®Google Scholar
• Takeshita T., Goto Y., Tada K., Nagata K., Asao H., Sugamura K. Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor. Journal of Experimental Medicine 1989; 169: 1323–32
   PubMed Web of Science ®Google Scholar
• Hatakeyama M., Tsudo M., Minamoto S., Kono T., Doi T., Miyata T., Miyasaka M., Taniguchi T. Interleukin-2 receptor β chain gene: Generation of three receptor forms by cloned human α and β chain cDNA's. Science 1989; 244: 551–6
   PubMed Web of Science ®Google Scholar
• Hatakeyama M., Mori H., Doi T., Taniguchi T. A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 1989; 59: 837–45
   PubMed Web of Science ®Google Scholar
• D'Andrea A. D., Lodish H. F., Wong G. W. Expression cloning of the murine erythropoietin receptor. Cell 1989; 57: 277–85
   PubMed Web of Science ®Google Scholar
• D'Andrea A. D., Fasman G. D., Lodish H. F. Erythropoietin receptor and interleukin-2 receptor β chain: A new receptor family. Cell 1989; 58: 1023–4
   PubMed Web of Science ®Google Scholar
• Itoh N., Yonehara S., Schreurs J., Gorman D. M., Maruyama K., Ishii A., Yahara I., Arai K.-I., Miyajima A. Cloning of an interleukin-3 receptor gene: A member of a distinct receptor gene family. Science 1990; 247: 324–7
   PubMed Web of Science ®Google Scholar
• Mosley B., Beckmann M. P., March C. J., Idzerda R. L., Gimpel S. D., VandanBos T., Friend D., Alpert A., Anderson D., Jackson J., Wignall J. M., Smith C., Gallis B., Sims J. E., Urdal D., Widmer M. B., Cosman D., Park L. S. The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms. Cell 1989; 59: 335–48
   PubMed Web of Science ®Google Scholar
• Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN β 2) receptor. Science 1988; 241: 825–8
   PubMed Web of Science ®Google Scholar
• Goodwin R. G., Friend D., Ziegler S. F., Jerzy R., Falk B. A., Gimpel S., Cosman D., Dower S. K., March C.J., Namen A. E., Park L. S. Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily. Cell 1990; 60: 941–51
   PubMed Web of Science ®Google Scholar
• Gearing D. P., King J. A., Gough N. M., Nicola N. A. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO Journal 1989; 8: 3667–76
   PubMed Web of Science ®Google Scholar
• Fukunaga R., Ishizaka-Ikeda E., Seto Y., Nagata S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 1990; 61: 341–50
   PubMed Web of Science ®Google Scholar
• Ohashi Y., Takeshita T., Nagata K., Mori S., Sugamura K. Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. Journal of Immunology 1989; 143: 3548–55
   PubMed Web of Science ®Google Scholar
• Yagita H., Nakata M., Azuma A., Nitta T., Takeshita T., Sugamura K., Okumura K. Activation of peripheral blood T cells via the p75 interleukin 2 receptor. Journal of Experimental Medicine 1989; 170: 1445–50
   PubMed Web of Science ®Google Scholar
• Kamio M., Uchiyama T., Kodaka T., Ishikawa T., Onishi R., Uchino H., Yoneda N., Tatsumi E., Yamaguchi N. Selective expression of the p70 subunit of the interleukin-2 receptor on lymphocytes from patients with infectious mononucleosis. Blood 1990; 75: 415–20
   PubMed Web of Science ®Google Scholar
• Phillips J. H., Takeshita T., Sugamura K., Lanier L. L. Activation of natural killer cells via the p75 interleukin 2 receptor. Journal of Experimental Medicine 1989; 170: 291–6
   PubMed Web of Science ®Google Scholar
• Caligiuri M. A., Zmuidzinas A., Manley T. J., Levine H., Smith K. A., Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high-affinity receptors. Journal of Experimental Medicine 1990; 171: 1509–26
   PubMed Web of Science ®Google Scholar
• Nagler A., Lanier L. L., Phillips J. H. Constitutive expression of high affinity interleukin 2 receptors on human CD16− natural killer cells in vivo. Journal of Experimental Medicine 1990; 171: 1527–33
   PubMed Web of Science ®Google Scholar
• Tsudo M., Uchiyama T., Uchino H. Expression of Tac antigen on activated normal human B cells. Journal of Experimental Medicine 1984; 160: 612–7
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Goldman C. K., Robb R. J., Depper J. M., Leonard W. J., Sharrow S. O., Bongiovanni K. F., Korsmeyer S. J., Greene W. C. Expression of interleukin 2 receptors on activated human B cells. Journal of Experimental Medicine 1984; 160: 1450–66
   PubMed Web of Science ®Google Scholar
• Saiki O., Tanaka T., Doi S., Kishimoto S. Expression and the functional role of a p70/75 interleukin 2-binding molecule in human B cell. Journal of Immunology 1988; 140: 853–8
   PubMed Web of Science ®Google Scholar
• Tanaka T., Saiki O., Doi S., Suemura M., Negoro S., Kishimoto S. Expression of novel interleukin 2 binding molecules and their functional roles in human B cell differentiation. Journal of Clinical Investigation 1988; 82: 316–21
   PubMed Web of Science ®Google Scholar
• Hermann F., Cannistra S. A., Levine H., Griffin J. D. Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. Journal of Experimental Medicine 1985; 162: 1111–6
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Lai A. P., Roberts P. J., Cawley J. C. Certain myeloid cells possess receptors for interleukin-2. British Journal of Haematology 1986; 64: 799–807
   PubMed Web of Science ®Google Scholar
• West W. H., Trauer K. W., Yannelli J. R., Marshall G. D., Orr D. W., Thurman G. B., Oldham R. K. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. New England Journal of Medicine 1987; 316: 898–905
   PubMed Web of Science ®Google Scholar
• Oshimi K., Oshimi Y., Akutsu M., Takei Y., Saito H., Okada M., Mizoguchi H. Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells. Blood 1986; 68: 938–48
   PubMed Web of Science ®Google Scholar
• Lotzova E., Savary C. A., Herberman R. B. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2. Journal of Immunology 1987; 138: 2718–27
   PubMed Web of Science ®Google Scholar
• Lotzova E., Savary C. A., Herberman R. B. Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors. Leukemia Research 1987; 11: 1059–66
   PubMed Web of Science ®Google Scholar
• Fierro M. T., Xin-Sheng L., Lusso P., Bonferroni M., Matera L., Cesano A., Arione R., Forni G., Foa R. In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity. Leukemia 1988; 2: 50–4
   PubMed Web of Science ®Google Scholar
• Lista P., Fierro M. T., Xin-Sheng L., Bonferroni M., Brizzi M. F., Porcu P., Pegoraro L., Foa R. Lymphokine-activated killer (LAK) cells inhibited the clonogenic growth of leukemic stem cells. European Journal of Haematology 1989; 42: 425–30
   PubMed Web of Science ®Google Scholar
• Foa R., Meloni G., Tosti S., Novarino A., Fenu S., Gavosto F., Mandelli F. Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study. British Journal of Haematology 1991; 77: 491–6
   PubMed Web of Science ®Google Scholar
• Gottlieb D. J., Prentice H. G., Heslop H. E., Bello-Fernandez C., Bianchi A. C., Galazka A. R., Brenner M. K. Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy. Blood 1989; 74: 2335–42
   PubMed Web of Science ®Google Scholar
• Visani G., Delwel R., Touw I., Bot F., Löwenberg B. Membrane receptors for interleukin 2 hematopoietic precursors in chronic myeloid leukemia. Blood 1987; 69: 1182–7
   PubMed Web of Science ®Google Scholar
• Birchenall-Sparks M. C., Farrar W. L., Rennick D., Killian P. L., Ruscetti F. W. Regulation of expression of the interleukin 2 receptor on hematopoietic cells by interleukin 3. Science 1986; 233: 455–8
   PubMed Web of Science ®Google Scholar
• Yamamoto S., Hattori T., Matsuoka M., Ishii T., Asou N., Okada M., Tagaya Y., Yodoi J., Takatsuki K. Induction of Tac antigen and proliferation of myeloid leukemic cells by ATL-derived factor: comparison with other agents that promote differentiation of human myeloid or monocytic leukemic cells. Blood 1986; 67: 1714–20
   PubMed Web of Science ®Google Scholar
• Erber W. N., Phil D., Mason D. Y. Expression of the interleukin-2 receptor (Tac antigen/CD25) in hematologic neoplasms. American Journal of Clinical Pathology 1988; 89: 645–8
   PubMed Web of Science ®Google Scholar
• Rosolen A., Nakanishi M., Poplack D. G., Cole D., Quinones R., Reaman G., Trepel J. B., Cotelingam J. D., Sausville E. A., Marti G. E., Jaffe E. S., Neckers L. M., Colamonici O. R. Expression of interleukin-2 receptor β subunit in hematopoietic malignancies. Blood 1989; 73: 1968–72
   PubMed Web of Science ®Google Scholar
• Allouche M., Sahraoui Y., Augery-Bourget Y., Ohashi Y., Sugamura K., Jasmin C., Georgoulias V. Presence of a p70 IL-2-binding peptide on leukemic cells from various hemopoietic lineages. Journal of Immunology 1989; 143: 2223–9
   PubMed Web of Science ®Google Scholar
• Hoshino S., Oshimi K., Tsudo M., Miyasaka M., Teramura M., Masuda M., Motoji T., Mizoguchi H. Flow cytometric analysis of expression of interleukin-2 receptor β chain (p70 75) on various leukemic cells. Blood 1990; 76: 767–74
   PubMed Web of Science ®Google Scholar
• O'Brien D., Boughton B. High and low affinity IL-2 receptors on human leukaemic blast cells. British Journal of Haematology 1990; 76: 315–7
   PubMed Web of Science ®Google Scholar
• Barnett D., Granger V., Reilly J. T. Expression of the p75 interleukin-2 receptor (β subunit) in acute and chronic leukaemia. British Journal of Haematology 1990; 76: 314–5
   PubMed Web of Science ®Google Scholar
• Carron J. A., Cawley J. C. IL-2 and myelopoiesis: IL-2 induces blast cell proliferation in some cases of acute myeloid leukaemia. British Journal of Haematology 1989; 73: 168–72
   PubMed Web of Science ®Google Scholar
• Foa R., Caretto P., Fierro M. T., Bonferroni M., Cardona S., Guarini A., Lista P., Pegoraro L., Mandelli F., Forni G., Gavosto F. Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin. British Journal of Haematology 1990; 75: 34–40
   PubMed Web of Science ®Google Scholar
• MacDonald D., Jiang Y. Z., Swirsky D., Vulliamy T., Morilla R., Bungey J., Barrett A. J. Acute myeloid leukaemia relapsing following interleukin-2 treatment express the alpha chain of the interleukin-2 receptor. British Journal of Haematology 1991; 77: 43–9
   PubMed Web of Science ®Google Scholar
• Touw I., Delwel R., Bolhuis R., van Zanen G., Löwenberg B. Common and pre-B acute lymphoblastic leukemia cells express interleukin 2 receptors, and interleukin 2 stimulates in vitro colony formation. Blood 1985; 66: 556–61
   PubMed Web of Science ®Google Scholar
• Matsuoka M., Hattori T., Kawano F., Ishii T., Uchiyama T., Takatsuki K. Expression of Tac antigen on human immature B-cell lineage leukemic cells. Leukemia Research 1986; 10: 597–603
   PubMed Web of Science ®Google Scholar
• Wörmann B., Anderson J. M., Ling Z. D., LeBien T. W. Structure/function analysis of IL-2 binding proteins on human B cell precursor acute lymphoblastic leukemias. Leukemia 1987; 1: 660–6
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Cawley J. C. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation. Clinical and Experimental Immunology 1986; 63: 298–302
   PubMed Web of Science ®Google Scholar
• Touw I., Dorssers L., Löwenberg B. The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors. Blood 1987; 69: 1667–73
   PubMed Web of Science ®Google Scholar
• Begley C. G., Burton J. D., Tsudo M., Brownstein B. H., Ambrus J. L., Jr., Waldmann T. A. Human B lymphocytes express the p75 component of the interleukin 2 receptor. Leukemia Research 1990; 14: 263–71
   PubMed Web of Science ®Google Scholar
• Yagura H., Tamaki T., Furitsu T., Tomiyama Y., Nishiura T., Tominaga N., Katagiri S., Yonezawa T., Tarui S. Demonstration of high-affinity interleukin-2 receptors on B-chronic lymphocytic leukemia cells: Functional and structural characterization. Blut 1990; 60: 181–6
   PubMedGoogle Scholar
• Korsmeyer S. J., Greene W. C., Cossman J., Hsu S.-M., Jensen J. P., Neckers L. M., Marshall S. L., Bakhshi A., Depper J. M., Leonard W. J., Jaffe E. S., Waldmann T. A. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proceedings of the National Academy of Science of the United States of America 1983; 80: 4522–6
   PubMed Web of Science ®Google Scholar
• Kodaka T., Uchiyama T., Ishikawa T., Kamio M., Onishi R., Itoh K., Hori T., Uchino H., Tsudo M., Araki K. Interleukin-2 receptor β-chain (p70–75) expressed on leukemic cells from adult T cell leukemia patients. Japanese Journal of Cancer Research 1990; 81: 902–8
   PubMedGoogle Scholar
• Oshimi K. Granular lymphocyte proliferative disorders: Report of 12 cases and review of the literature. Leukemia 1988; 2: 617–27
   PubMed Web of Science ®Google Scholar
• Loughran T. P., Starkebaum G. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine 1987; 66: 397–405
   PubMed Web of Science ®Google Scholar
• Semenzato G., Pandolfi F., Chisesi T., DeRossi G., Pizzolo G., Zambello R., Trentin L., Agostini C., Dini E., Vespignani M., Cafaro A., Pasqualetti D., Giubellino M. C., Migone N., Foá R. The lymphoproliferative disease of granular lymphocytes: A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 1987; 60: 2971–8
   PubMed Web of Science ®Google Scholar
• Colamonici O. R., Quinones R., Rosolen A., Trepel J. B., Sausville E., Phares J. C., Gress R., Poplack D., Weber J., Schechter G. P., Neckers L. M. The beta subunit of the interleukin-2 receptor mediates interleukin-2 induction of anti-CD3 redirected cytotoxic capability in larger granular lymphocytes. Blood 1988; 71: 825–8
   PubMed Web of Science ®Google Scholar
• Tagawa S., Hatakeyama M., Shibano M., Taniguchi T., Kitani T. The expression of the p75 subunit of interleukin 2 receptor in Tac negative leukemic cells of two patients with large granular lymphocytic leukemia. Blood 1988; 71: 1161–4
   PubMed Web of Science ®Google Scholar
• Hori T., Uchiyama T., Onishi R., Kamio M., Umadome H., Tamori S., Motoi T., Kodaka T., Uchino H. Characteristics of the IL-2 receptor expressed on large granular lymphocytes from patients with abnormally expanded large granular lymphocytes. Journal of Immunology 1988; 140: 4199–203
   PubMed Web of Science ®Google Scholar
• Zambello R., Trentin L., Pizzolo G., Bulian P., Masciarelli M., Feruglio C., Agostini C., Raimondi R., Chisesi T., Semenzato G. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes. Blood 1990; 76: 2080–5
   PubMed Web of Science ®Google Scholar
• Hoshino S., Oshimi K., Teramura M., Mizoguchi H. Activation via the CD3 and CD16 pathway mediates interleukin-2 dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders. Blood 1991, (in press)
   PubMed Web of Science ®Google Scholar
• Sheibani K., Winberg C. D., Van de Velde S., Blayney D. W., Rappaport H. Distribution of lymphocytes with interleukin-2 receptors (Tac antigens) in reactive lymphoproli-ferative processes, Hodgkin's disease, and Non-Hodgkin's lymphomas. An immunohistologic study of 300 cases. American Journal of Pathology 1987; 127: 27–37
   PubMed Web of Science ®Google Scholar
• Debatin K.-M., Woodroofe C., Lahm H., Fischer J., Falk W., Brandeis W. E., Krammer P. H. Lack of interleukin-2 (IL-2) dependent growth of Tac positive T-ALL/NHL cells is due to the expression of only low affinity receptors for IL-2. Leukemia 1989; 3: 566–71
   PubMed Web of Science ®Google Scholar
• Peuchmaur M., Emilie D., Crevon M. C., Solal-Celigny P., Maillot M. C., Lemaigre G., Galanaud P. IL-2 mRNA expression in Tac-positive malignant lymphomas. American Journal of Pathology 1990; 136: 383–90
   PubMed Web of Science ®Google Scholar
• Benjamin D., Rosolen A., Wormsley S. B., DeBault L. E., Colamonici O. R. Expression of low-, intermediate-, and high-affinity IL-2 receptors on B cell lines derived from patients with undifferentiated lymphoma of Burkitt's and non-Burkitt's types. Cellular Immunology 1990; 129: 112–24
   PubMed Web of Science ®Google Scholar